What Bacteria Causes SIBO: Types and Symptoms

Small intestinal bacterial overgrowth, or SIBO, is driven primarily by two species from the Proteobacteria family: Escherichia coli and Klebsiella. This contradicts the older idea that SIBO results from colon bacteria migrating backward into the small intestine. Next-generation DNA sequencing has shown the picture is more specific than that, and the symptoms you experience depend not just on which organisms are overgrown but on what gases they produce during fermentation.

The Bacteria Behind SIBO

For decades, doctors assumed SIBO was caused by colonic flora creeping upstream into the small bowel. Older culture techniques reinforced this idea because the sampling catheters used could easily become contaminated by bacteria from the mouth or throat on the way down. Modern sequencing technology has changed the story. A study using shotgun DNA sequencing of duodenal fluid found that two main E. coli strains and two Klebsiella species accounted for roughly 40% of all duodenal bacteria in people meeting SIBO culture thresholds.¹ As bacterial counts climbed, the diversity of other microbes in the small intestine actually dropped, meaning these two species were crowding out the normal residents rather than joining a diverse invasion from the colon.²

A separate sequencing study of duodenal samples confirmed the pattern and added a few more names to the list. Along with Klebsiella and Escherichia/Shigella (which were each about seven to eight times more abundant in SIBO patients than in controls), smaller increases were seen in Acinetobacter and organisms from the Aeromonadaceae family.³ Broader reviews also mention Streptococcus, Staphylococcus, Bacteroides, Lactobacillus, and Proteus as organisms commonly found in elevated numbers.⁴ But the emerging consensus is that the core culprits, especially at the highest bacterial loads, are the E. coli and Klebsiella strains.

Three Gas Types, Three Symptom Profiles

What makes SIBO tricky is that the label covers at least three distinct patterns, each defined by the gas the overgrowing organisms produce. The gas matters because it shapes your dominant symptoms and guides treatment choices. In clinical practice, these are often discussed as hydrogen-dominant SIBO, methane-dominant overgrowth, and hydrogen-sulfide SIBO.

Most SIBO patients produce excess hydrogen. This happens when bacteria ferment carbohydrates you eat, releasing hydrogen gas as a byproduct. The hallmark symptoms are bloating, abdominal pain, and diarrhea.⁵ Hydrogen itself does not appear to slow the gut. Instead, the osmotic effects of bacterial fermentation and the irritation of the intestinal lining drive loose stools and urgency. This is the form of SIBO that overlaps most with diarrhea-predominant irritable bowel syndrome.

Methane Producers and Constipation

About 30% of SIBO patients harbor archaea, a group of microorganisms that are technically not bacteria but are lumped into the SIBO conversation because they overgrow in the same location.⁶ The dominant species is Methanobrevibacter smithii, which consumes the hydrogen that other bacteria produce and converts it into methane. This is now often called intestinal methanogen overgrowth, or IMO, to acknowledge that archaea are a separate domain of life from bacteria.

The clinical picture with methane is almost the opposite of hydrogen-dominant SIBO. Methane appears to slow intestinal transit by acting on the gut’s neuromuscular system, leading to constipation rather than diarrhea.⁷ Studies of people with constipation-predominant IBS have found significantly higher loads of M. smithii compared with both healthy people and those with diarrhea-type IBS. In one study, the copy number of M. smithii was inversely linked to stool frequency: the more methanogens, the fewer bowel movements per day.⁸ Hard, pellet-like stools (Bristol types 1 and 2) were associated with the highest methanogen loads.

Hydrogen Sulfide and the Diarrhea Connection

A third gas, hydrogen sulfide, is gaining attention as a contributor to SIBO symptoms. Like methane producers, hydrogen-sulfide producers are specialized organisms that consume hydrogen and reduce sulfate compounds in the process. The key genera implicated are Fusobacterium and Desulfovibrio. In people with diarrhea-predominant IBS, higher breath hydrogen sulfide levels correlated with higher relative abundance of these sulfate-reducing bacteria, and metabolic pathway analysis confirmed enrichment of sulfate reduction pathways in their gut microbiomes.⁹

Hydrogen sulfide SIBO is still the least well-characterized of the three. Only recently have clinical breath-testing devices become capable of measuring hydrogen sulfide alongside hydrogen and methane. Patients with this form tend to report diarrhea, bloating, and sometimes a distinctive sulfurous odor to gas and stool. Because hydrogen-sulfide producers compete with methanogens for the same hydrogen substrate, the two patterns rarely coexist at high levels in the same person.

How the Small Intestine Normally Keeps Bacteria in Check

Understanding why SIBO develops means understanding the defenses that normally prevent it. The healthy small intestine stays relatively low in bacteria compared with the colon, thanks to several cooperating mechanisms. Stomach acid kills many organisms before they reach the small bowel. Bile has antimicrobial properties. Pancreatic enzymes break down bacterial biofilms. And the ileocecal valve, a muscular ring between the small and large intestines, acts as a physical barrier against colonic bacteria moving upstream.

Perhaps the most important defense is the migrating motor complex, or MMC, a wave-like contraction pattern that sweeps through the small intestine during fasting. Phase III of the MMC is the most vigorous phase and has long been called the “housekeeper” of the gut because it clears residual food debris and bacteria from the small bowel.¹⁰ When the MMC fails, bacteria that would normally be swept downstream into the colon linger and multiply. Research suggests SIBO patients have roughly 60% less MMC-related clearance than healthy individuals.¹¹

The ileocecal valve also plays a measurable role. In people with a positive SIBO breath test, valve pressures were significantly lower than in those who tested negative, suggesting that a weak valve lets colonic bacteria seep into the small intestine more easily.¹²

Acid-Suppressing Medications and SIBO Risk

Proton pump inhibitors (PPIs) are among the most commonly prescribed medications worldwide, and their connection to SIBO has become a well-studied concern. By suppressing stomach acid production, PPIs remove one of the body’s first-line defenses against ingested bacteria. A meta-analysis found that PPI use was associated with roughly a 70% higher odds of developing SIBO.¹³

The risk also appears to climb the longer someone stays on PPIs. A more recent systematic review and meta-analysis found that each additional month of PPI use was associated with about a four-percentage-point increase in SIBO prevalence.¹⁴ This does not mean everyone on a PPI will develop SIBO, but it is one of the clearest modifiable risk factors, and it becomes especially relevant for people already prone to SIBO for other reasons.

Common Symptoms Across All Types

Regardless of which gas type dominates, SIBO tends to produce a recognizable cluster of digestive complaints. The most frequently reported are bloating, abdominal pain or cramping, excess gas, and altered bowel habits. Weight loss, fatigue, and a general sense of weakness are common when SIBO has been present for a while.⁴ The distinction between hydrogen-dominant and methane-dominant forms shows up mainly in bowel habits: diarrhea or loose stools in the first case, constipation and hard stools in the second, with hydrogen-sulfide SIBO leaning toward the diarrhea end.

What trips up many patients is that these symptoms overlap heavily with ordinary IBS, celiac disease, lactose intolerance, and a handful of other conditions. SIBO is not always the first thing a doctor suspects, especially in people without an obvious structural or motility risk factor. The evolving understanding of SIBO’s bacterial specifics has not yet solved the diagnostic-overlap problem.

Nutrient Deficiencies That Signal Longstanding SIBO

When bacteria overgrow in the small intestine, they compete with you for nutrients. They can also damage the intestinal lining, impairing absorption. The specific deficiencies that develop appear to depend partly on the SIBO subtype. In one study, people with both hydrogen and methane positivity on breath testing were more likely to have low vitamin D and low ferritin (a marker of iron stores), while those with methane alone tended to have elevated folic acid, likely because certain gut bacteria synthesize it as a byproduct.¹⁵

Vitamin B12 deficiency is another classic finding in longstanding SIBO because bacteria in the small intestine consume B12 before your body can absorb it. Fat-soluble vitamin deficiencies (A, D, E, K) can develop when bacterial activity disrupts bile acid metabolism and impairs fat digestion. If you have unexplained anemia, low vitamin D, or signs of fat malabsorption like oily stools, SIBO is worth investigating even if your symptoms seem mild on the surface.

How SIBO Gets Diagnosed

There are two main diagnostic approaches. The gold standard, at least in theory, is aspirating fluid directly from the small intestine during an endoscopy and culturing it. If bacterial counts exceed a threshold (classically 100,000 colony-forming units per milliliter of gram-negative flora), that confirms overgrowth.¹⁶ The catch is that aspiration is invasive, expensive, and can miss bacteria living farther down the intestine beyond the endoscope’s reach.

Breath testing is far more common in practice. You drink a sugar solution (glucose or lactulose), and the lab measures hydrogen and methane in your exhaled breath over the next few hours. Rising hydrogen or methane levels suggest bacterial fermentation in the small intestine. Glucose breath tests tend to have better agreement with aspiration cultures than lactulose breath tests do, but lactulose can detect overgrowth in the lower small intestine that glucose misses because glucose gets absorbed too quickly.¹⁷ Neither test is perfect. Both can produce false positives and false negatives, which is one reason SIBO remains a frustrating diagnosis for patients and clinicians alike.

Conditions That Make SIBO More Likely

SIBO does not usually appear in a vacuum. Certain conditions create the perfect environment for bacterial overgrowth by compromising one or more of the defenses described earlier. Structural issues like surgical blind loops (the original “blind loop syndrome” that gave SIBO its first clinical identity), intestinal strictures, and small bowel diverticula create pockets where bacteria can stagnate.¹⁸ Motility disorders like diabetic gastroparesis, scleroderma, and post-surgical adhesions impair the MMC. Immune deficiency syndromes reduce the body’s ability to keep bacterial populations in check.

Systemic sclerosis (scleroderma) is one of the best-studied associations. About 40% of people with scleroderma have SIBO, representing roughly a tenfold increase compared with healthy controls.¹⁹ This makes sense because scleroderma damages the smooth muscle of the intestinal wall, severely impairing motility. The connection is important clinically: if you have scleroderma and unexplained GI symptoms, SIBO testing should be on the table.

Why SIBO Keeps Coming Back

One of the most frustrating aspects of SIBO is its tendency to recur after treatment. The standard first-line antibiotic, rifaximin, works well for initial eradication. But studies tracking patients after successful antibiotic therapy found that about 13% tested positive again at three months, 28% at six months, and 44% at nine months.²⁰ Other reviews report similar recurrence rates of roughly 40–45% within the first year.²¹

The factors that predict recurrence paint a logical picture. Older age, chronic PPI use, and a history of appendectomy were all independently associated with SIBO returning after treatment.²⁰ These make sense: age tends to slow motility, PPIs reduce the acid barrier, and the appendix may play a role in regulating the gut immune environment. Because antibiotics kill the overgrown bacteria but do not fix the underlying motility or structural problem, the conditions that allowed SIBO to develop in the first place remain after the antibiotic course ends. This is why many practitioners now add prokinetic medications after antibiotic treatment, aiming to restore the MMC’s sweeping function and reduce relapse risk.¹¹

When Fungal Overgrowth Overlaps

SIBO is not the only kind of small intestinal overgrowth. A related condition called SIFO, or small intestinal fungal overgrowth, involves an excess of yeast (typically Candida species) in the same location. The two conditions frequently coexist: roughly a third of people with SIBO also end up being diagnosed with SIFO.²² The symptoms are nearly identical, which means a patient who does not improve after SIBO treatment may have unrecognized fungal overgrowth as well. SIFO does not show up on breath tests; it requires aspiration and fungal culture or specialized staining, making it easy to miss.

Beyond the Gut

There is growing recognition that SIBO can cause problems well beyond digestive symptoms. Emerging research links it to metabolic, neurological, cardiovascular, skin, and autoimmune conditions, though much of this evidence comes from observational studies and animal models rather than large clinical trials.²³ The proposed mechanism is straightforward: an overgrown and damaged small intestinal lining becomes more permeable, allowing bacterial toxins and inflammatory molecules to enter the bloodstream. Whether treating SIBO improves these distant conditions remains an open and actively researched question.

Probiotics and the Colonization Concern

Many people with digestive problems reach for probiotics as a first step, but for SIBO patients this can sometimes backfire. Case reports and clinical observations have found that certain probiotic strains can colonize the small intestine in susceptible individuals, worsening overgrowth rather than correcting it. In some cases, probiotic-driven small bowel colonization has been linked to D-lactic acidosis and brain fogginess.²⁴ This does not mean all probiotics are harmful in SIBO. Some strains and formulations appear helpful, and clinical trials are ongoing. But the reflexive assumption that probiotics are always safe and beneficial does not hold for people whose underlying problem is too many organisms in the wrong place. If you suspect SIBO, adding probiotics without guidance can muddy both symptoms and test results.